Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery
期刊ISSN: 1746-0441
E-ISSN: 1746-045X
影响因子: 登录后查看数据
自引率: 2%
SCI期刊JCR分区
SCI期刊JCR分区等级:1区
按学科分区
PHARMACOLOGY & PHARMACY
Q1
PHARMACOLOGY & PHARMACY
Q2
《新锐期刊分区表》(2026年3月发布)
大类学科
医学
2区
小类学科
药学
2区
Top期刊
综述期刊
最新中科院SCI期刊分区(2025年3月升级版)
大类学科
医学
2区
小类学科
药学
2区
Top期刊
综述期刊
期刊简介
Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.
出版信息
出版商
Informa Healthcare
涉及的研究方向
医学-药学
刊期
Bimonthly
年文章数
78
出版国家或地区
ENGLAND
是否OA
Cite Score(2025年最新版)
Cite Score SJR SNIP 排名
10.6 1.195 1.071
学科
大类学科:Pharmacology, Toxicology and Pharmaceutics
小类学科:Drug Discovery
分区
Q1
SCI期刊投稿推荐
JCR分区相关期刊
中科院分区相关期刊
去登录